BACKGROUND: Human rhinoviruses (HRV) are now considered major respiratory pathogens. We sought to determine whether HRV are a cause of wheezing and/or hospitalization in children <2 years old. METHODS: A polymerase chain reaction assay was used to screen for HRV infection in 4 categories of children <2 years old: (1) with symptoms of respiratory tract disease without wheezing; (2) with wheezing with or without other symptoms; (3) who were asymptomatic and; (4) who had a respiratory specimen submitted to a diagnostic laboratory. All specimens were collected between January and December 2004. Phylogenetic analyses were performed on most HRV isolates. RESULTS: Twenty-eight (17%) of 165 children with symptoms of respiratory infection without wheezing; 21 (26.3%) of 80 children with wheezing; 3 (3%) of 93 asymptomatic children; and 47 (23.3%) of 202 children with specimens submitted to the diagnostic laboratory tested positive for HRV. The difference between the rates of infection in the asymptomatic group and in each of the 3 other categories was statistically significant (P </= 0.01). Among HRV-positive children with samples submitted to the diagnostic laboratory, 55% were hospitalized, which was similar to that observed for respiratory syncytial virus (52.7%) among children of a similar age group and time period (P = 0.85). Diverse groups of HRV were circulating during the 1-year study period. CONCLUSIONS: HRV are important pathogens among children <2 years old and are responsible for a significant proportion of wheezing this age group. The hospitalization rates of HRV-positive children seem to be similar to that of respiratory syncytial virus.
BACKGROUND: Human rhinoviruses (HRV) are now considered major respiratory pathogens. We sought to determine whether HRV are a cause of wheezing and/or hospitalization in children <2 years old. METHODS: A polymerase chain reaction assay was used to screen for HRV infection in 4 categories of children <2 years old: (1) with symptoms of respiratory tract disease without wheezing; (2) with wheezing with or without other symptoms; (3) who were asymptomatic and; (4) who had a respiratory specimen submitted to a diagnostic laboratory. All specimens were collected between January and December 2004. Phylogenetic analyses were performed on most HRV isolates. RESULTS: Twenty-eight (17%) of 165 children with symptoms of respiratory infection without wheezing; 21 (26.3%) of 80 children with wheezing; 3 (3%) of 93 asymptomatic children; and 47 (23.3%) of 202 children with specimens submitted to the diagnostic laboratory tested positive for HRV. The difference between the rates of infection in the asymptomatic group and in each of the 3 other categories was statistically significant (P </= 0.01). Among HRV-positive children with samples submitted to the diagnostic laboratory, 55% were hospitalized, which was similar to that observed for respiratory syncytial virus (52.7%) among children of a similar age group and time period (P = 0.85). Diverse groups of HRV were circulating during the 1-year study period. CONCLUSIONS:HRV are important pathogens among children <2 years old and are responsible for a significant proportion of wheezing this age group. The hospitalization rates of HRV-positive children seem to be similar to that of respiratory syncytial virus.
Authors: K Loens; H Goossens; C de Laat; H Foolen; P Oudshoorn; S Pattyn; P Sillekens; M Ieven Journal: J Clin Microbiol Date: 2006-01 Impact factor: 5.948
Authors: G P Rakes; E Arruda; J M Ingram; G E Hoover; J C Zambrano; F G Hayden; T A Platts-Mills; P W Heymann Journal: Am J Respir Crit Care Med Date: 1999-03 Impact factor: 21.405
Authors: Peter F Wright; Anne M Deatly; Ruth A Karron; Robert B Belshe; Jian R Shi; William C Gruber; Yuwei Zhu; Valerie B Randolph Journal: J Clin Microbiol Date: 2007-05-02 Impact factor: 5.948
Authors: E Kathryn Miller; Xiaoyan Lu; Dean D Erdman; Katherine A Poehling; Yuwei Zhu; Marie R Griffin; Tina V Hartert; Larry J Anderson; Geoffrey A Weinberg; Caroline B Hall; Marika K Iwane; Kathryn M Edwards Journal: J Infect Dis Date: 2007-02-02 Impact factor: 5.226
Authors: Linda C Ede; Michael J Loeffelholz; Pedro Alvarez-Fernandez; Dan L Pong; Janak A Patel; David P McCormick; Tasnee Chonmaitree Journal: Pediatr Infect Dis J Date: 2012-11 Impact factor: 2.129
Authors: Helen Y Chu; Janet A Englund; Bonnie Strelitz; Kirsten Lacombe; Charla Jones; Kristin Follmer; Emily K Martin; Miranda Bradford; Xuan Qin; Jane Kuypers; Eileen J Klein Journal: J Pediatric Infect Dis Soc Date: 2014-10-19 Impact factor: 3.164
Authors: Ana Isabel M P Monteiro; Nancy Cristina J Bellei; Alessandra Ramos Sousa; Amélia Miyashiro N dos Santos; Lily Yin Weckx Journal: Rev Paul Pediatr Date: 2014-06
Authors: E Kathryn Miller; Jodell Linder; David Kraft; Monika Johnson; Pengcheng Lu; Benjamin R Saville; John V Williams; Marie R Griffin; H Keipp Talbot Journal: J Allergy Clin Immunol Date: 2015-08-06 Impact factor: 10.793
Authors: E Kathryn Miller; John V Williams; Tebeb Gebretsadik; Kecia N Carroll; William D Dupont; Yassir A Mohamed; Laura-Lee Morin; Luke Heil; Patricia A Minton; Kimberly Woodward; Zhouwen Liu; Tina V Hartert Journal: J Allergy Clin Immunol Date: 2011-01-26 Impact factor: 10.793